Executive Director, US Brand Lead, Neurology

<div class="content-intro"><div><strong>Why Join Us?</strong></div> <div> </div> <div><em>Be a hero for our rare disease patients</em></div> <div><em> </em></div> <div>At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them. </div> <div> </div> <div>Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work.</div> <div> </div> <div>If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team<em>. </em></div></div><h3 style="text-align: left;"><strong>Position Summary:</strong></h3> <p style="text-align: left;"><em><strong>ultra</strong>dedicated – Your biggest challenges yield rare possibilities</em></p> <p style="text-align: left;"><span class="TextRun SCXW64085190 BCX0" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW64085190 BCX0">Ultragenyx is preparing for the potential commercialization of a rare disease </span><span class="NormalTextRun SCXW64085190 BCX0">Antisense oligonucleotide</span><span class="NormalTextRun SCXW64085190 BCX0"> therapy for the treatment of </span><span class="NormalTextRun SCXW64085190 BCX0">Angelman S</span><span class="NormalTextRun SCXW64085190 BCX0">yndrome</span><span class="NormalTextRun SCXW64085190 BCX0">.</span><span class="NormalTextRun SCXW64085190 BCX0"> </span><span class="NormalTextRun SCXW64085190 BCX0">The Executive Directo</span><span class="NormalTextRun SCXW64085190 BCX0">r</span><span class="NormalTextRun SCXW64085190 BCX0">, US </span><span class="NormalTextRun SCXW64085190 BCX0">Brand Lead</span><span class="NormalTextRun SCXW64085190 BCX0">, </span><span class="NormalTextRun SCXW64085190 BCX0">Neurology</span> <span class="NormalTextRun SCXW64085190 BCX0">Therapeutic Area</span><span class="NormalTextRun SCXW64085190 BCX0"> will</span><span class="NormalTextRun SCXW64085190 BCX0"> lead the </span><span class="NormalTextRun SCXW64085190 BCX0">US </span><span class="NormalTextRun SCXW64085190 BCX0">launch</span><span class="NormalTextRun SCXW64085190 BCX0"> with accountability for pre-launch</span><span class="NormalTextRun SCXW64085190 BCX0"> activities and execution of commercial launch</span><span class="NormalTextRun SCXW64085190 BCX0">. </span><span class="NormalTextRun SCXW64085190 BCX0">Candidates must have </span><span class="NormalTextRun SCXW64085190 BCX0">a track record</span><span class="NormalTextRun SCXW64085190 BCX0"> of b</span><span class="NormalTextRun SCXW64085190 BCX0">uil</span><span class="NormalTextRun SCXW64085190 BCX0">ding</span><span class="NormalTextRun SCXW64085190 BCX0"> a blockbuster rare disease, neurology, pediatric and adult break through treatment seeing through from launch to peak year growth</span><span class="NormalTextRun SCXW64085190 BCX0">.</span><span class="NormalTextRun SCXW64085190 BCX0"> </span></span><span class="TextRun SCXW64085190 BCX0" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW64085190 BCX0">The role will report to the SVP, H ... (truncated, view full listing at source)